BBL
EXAS

Beck Bode LLC’s Exact Sciences EXAS Stock Holding History

Beck Bode LLC’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-52,603
Closed -$3.59M – 132
2023
Q3 		$3.59M Sell
52,603
-1,593
-3% -$135K 0.92% 40
2023
Q2 		$5.05M Buy
54,196
+41,672
+333% +$3.25M 1.23% 27
2023
Q1 		$849K Sell
12,524
-16,624
-57% -$1.07M 0.21% 104
2022
Q4 		$1.44M Buy
+29,148
New +$1.19M 0.32% 76

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Beck Bode LLC's EXAS Position: Q4 2023 in Review

Beck Bode LLC sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 52,603 shares — an estimated $3.59M sold.

Beck Bode LLC first reported a position in EXAS in Q4 2022 and held it in 4 quarters. The position peaked at $5.05M in Q2 2023. 647 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Beck Bode LLC reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • Beck Bode LLC sold 52,603 Exact Sciences shares in Q4 2023, an estimated $3.59M.
  • Beck Bode LLC first reported a position in Exact Sciences in Q4 2022 and held it in 4 quarters.
  • Beck Bode LLC's Exact Sciences position peaked at $5.05M in Q2 2023.
  • 647 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Beck Bode LLC's 13F filing for Q4 2023, filed 5 Feb 2024.